Compare UBSI & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UBSI | TWST |
|---|---|---|
| Founded | 1982 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 7.4B |
| IPO Year | 1994 | 2018 |
| Metric | UBSI | TWST |
|---|---|---|
| Price | $47.08 | $118.08 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 13 |
| Target Price | $51.67 | ★ $128.92 |
| AVG Volume (30 Days) | 743.6K | ★ 2.3M |
| Earning Date | 10-22-2026 | 11-12-2026 |
| Dividend Yield | ★ 3.22% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.77 | N/A |
| Revenue | $311,957,000.00 | ★ $459,433,000.00 |
| Revenue This Year | $4.32 | $21.01 |
| Revenue Next Year | $5.54 | $18.75 |
| P/E Ratio | $17.03 | ★ N/A |
| Revenue Growth | N/A | ★ 22.00 |
| 52 Week Low | $35.55 | $25.67 |
| 52 Week High | $50.47 | $219.71 |
| Indicator | UBSI | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 44.91 | 41.08 |
| Support Level | $46.28 | $79.90 |
| Resistance Level | $47.77 | $153.47 |
| Average True Range (ATR) | 0.91 | 14.82 |
| MACD | -0.21 | -2.38 |
| Stochastic Oscillator | 6.38 | 28.56 |
United Bankshares Inc is a financial holding company that provides banking services. The company operates in one segment: Community banking, which offers a full range-of-products and services through various delivery channels. Included among the banking products and services offered are the acceptance of deposits in checking, savings, time, and money market accounts; the making and servicing of personal, credit card, commercial, and floor plan loans; and the making of construction and real estate loans, as well as the origination and sale of residential mortgages in the secondary market. Also offered are trust and brokerage services, safe deposit boxes, and wire transfers.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.